CURRICULUM VITAE Oklahoma Heart Hospital Physicians 4050 W. Memorial Rd., Third Floor (405)608-3800 Phone (405)608-3838 Fax
BUSINESS ADDRESS: Oklahoma Heart Hospital Physicians (OHHP) 4050 W. Memorial Rd, Third Floor 405-608-3800 Oklahoma Foundation for Cardiovascular Research (OFCR) Oklahoma Cardiovascular Research Group (OCRG) 4200 W. Memorial Rd, Suite 510 405-608-1280 PERSONAL DATA: Date of Birth: June 22, 1962 EDUCATION: Place of Birth: Citizenship: Norman, Oklahoma United States of America August 1980 May 1983 Degree: Bachelor of Science, Microbiology University of Oklahoma Norman, Oklahoma August 1984 May 1988 Degree: Doctor of Osteopathy Oklahoma State University College of Osteopathic Medicine Tulsa, Oklahoma POSTGRADUATE EDUCATION: Internship: July 1988 June 1989 Doctors Hospital Columbus, Ohio Residency: August 1989 July 1993 General Surgery Doctors Hospital Columbus, Ohio Fellowship: August 1993 July 1994 Peripheral Vascular Surgery Doctors Hospital Columbus, Ohio Rev: 4/11/2013 Page 2 of 6
BOARD CERTIFICATIONS: General Surgery May 22, 1996 American Osteopathic Board of Surgery General Vascular Surgery October 17, 1996 American Osteopathic Board of Surgery LICENSURE: STATE NUMBER ISSUE OK OH 3168 34.004779 1988 1989 DEA: US BM1886540 BNDD: MALPRACTICE INSURANCE POLICY: OK 23801 ProAssurance MP79414 1242 E. Independence Street, Suite 100 Springfield, Missouri 65804 800/492-7212 Phone 417/887-0300 Fax HOSPITAL AFFILIATIONS: PROFESSIONAL MEMBERSHIPS: PROFESSIONAL REFERENCES: Community Hospital Deaconess Hospital Grady Memorial Hospital McBride Orthopedic Hospital Mercy Hospital Oklahoma City Northwest Surgical Hospital Oklahoma Center for Orthopaedic & Multi-Specialty Surgery Oklahoma Heart Hospital Oklahoma Heart Hospital-South Oklahoma Spine Hospital Select Specialty Hospital Southwest Ambulatory Surgery Center St Anthony Hospital American Medical Association Oklahoma State Medical Association American College of Osteopathic Association American Osteopathic Association Oklahoma Osteopathic Association Oklahoma County Medical Society R. Mark Bodenhamer, M.D. 4050 W. Memorial Road, Third Floor 405 608-3800 John Randolph, M.D. Rev: 4/11/2013 Page 3 of 6
4050 W. Memorial Road, Third Floor 405 608-3800 Lenny Stubbs, M.D. 4050 W. Memorial Road, Third Floor 405 608-3800 PROFESSIONAL EXPERIENCE: June 1998 Present Oklahoma Heart Hospital Physicians (OHHP) Oklahoma City, Oklahoma CLINICAL INVESTIGATIONS: July 2001 Present Oklahoma Foundation for Cardiovascular Research (OFCR) Oklahoma Cardiovascular Research Group (OCRG) Oklahoma City, OK August 1994 May 1998 Southern Plains Medical Center Chickasha, Oklahoma Multi-center Double Blind, Placebo Controlled Study of AT 1015 in Patients with Intermittent Claudication Due To Peripheral Arterial Disease (AT 1015 PVD) Double Blind, Placebo Controlled Study of the Efficacy and Safety of BMS 207940, A Selective Endothelin A Receptor Antagonist, In Subjects with Intermittent Claudication (BMS PVD) Investigational Plan (Phase 2) for the Endologix Suprarenal Bifurcated Powerlink System (Abdominal Aortic/Aorto-Iliac Aneurysm Endoluminal Graft Study) (ENDOLOGIX Protocol 00-006) 7/13/01-10/29/07 Investigational Plan (Phase 2) for the Endologix Bifurcated Powerlink System (Abdominal Aortic/Aorto-Iliac Aneurysm Endoluminal Graft Study) (ENDOLOGIX Protocol 00-005) 03/15/02 10/29/07 A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Comparative Study of CS- 866 in Patients with Established Atherosclerosis (AIMS) 05/27/03 02/18/05 A Multi-Center, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study of Efficacy and Safety of Immune Modulation Therapy In Improving Walking Distance In Patients with Intermittent Claudication Secondary to Peripheral Arterial Disease (VASOGEN) 07/29/03 C A Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems (Carotid RX Acculink/Accunet Post-Approval Trial to Uncover Unanticipated or Rare Events (CAPTURE) 11/19/04 Rev: 4/11/2013 Page 4 of 6
A Multicenter, Randomized, Double-Blind, Parallel Group, 12 Week Study to Evaluate the Efficacy and Safety of MK-0524B Versus Atorvastatin in patients With Mixed Hyperlipidemia Biological Waste Material and Outcomes Analysis of Lower Extremity Peripheral Disease Treated With the Silver Hawk Plaque Excision System: A Tissue and Data Registry (BROADWING) 12/22/05 12/04/07 A Two-Part, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Simvastatin, Losartan, and Pioglitazone on Cardiovascular Disease Biomarkers in Lower Extremity Atherosclerotic Plaques Excised from Patients with Peripheral Arterial Disease (LEAP) 02/09/06 10/23/07 EVALUATE THE USE OF THE ENDOLOGIX 34MM Powerlink Cuff (Endologix 34MM) 02/27/06 Carotid Revascularization Endarterectomy VS. Stenting Trial - (CREST) 05/19/06 The Valiant Thoracic Stent Graft System Clinical Study, Investigational Plan #078 (VALOR II) 11/09/06 AAA 03-02, A Clinical Study Evaluating the Use of the GORE EXCLUDER Bifurcated Endoprosthesis 31mm In the Primary Treatment of Infrarenal Abdominal Aortic Aneurysms (GORE) 12/19/06 The NexStent Carotid Stent System: A post Market Approval Evaluation Study In Conjunction with the FilterWire EZ Embolic Protection System (SONOMA) 06/11/07 The Pivotal Study of the Aptus Endovascular AAA Repair System (STAPLE -2) 08/21/07 Carotid Stenting for High Surgical-Risk Patients; Evaluating Outcomes through the Collection of Clinical Evidence (CHOICE) 08/24/07 The Investigational Plan to Evaluate the Use of the Endologix 34mm Powerlink Cuff for Continued Access (ENDOLOGIX 34mm CA) 09/25/07 The Complete SE SFA Study The Medtronic Complete Self-Expanding SFA Stent System for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Proximal Popliteal Arteries (COMPLETE SE) 01/15/09 (Rheos ) Pivotal Trial 02/04/09 A Prospective, Non-Randomized, Multi-Center Clinical Trial to Evaluate the Safety and Efficacy of the Absolute Pro Peripheral Self-Expanding Stent System in Subjects with Atherosclerotic DeNovo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery (MOBILITY) 05/21/09 Health Outcomes Prospective Evaluation for Heart Failure with EF 40%, Document Number (HOPE4HF) 12/09/09 Rev: 4/11/2013 Page 5 of 6
A prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Usint the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture- Mediated Closure System, (PEVAR) 03/08/10 Rev: 4/11/2013 Page 6 of 6